Meharry Medical College

Nashville, Tennessee, US
Meharry Medical College banner
Meharry Medical College is a private, historically Black medical school in Nashville, Tennessee. Founded in 1876, it comprises the Schools of Medicine, Dentistry, Graduate Studies and Research, and Applied Computational Sciences. The college is noted for educating physicians, dentists, scientists, and public health leaders committed to serving underserved communities and advancing health equity.
Meharry Medical College’s research portfolio spans health disparities, HIV/AIDS, cancer biology, neuroscience, oral health, population health, and biomedical informatics. Flagship entities include the Meharry–Vanderbilt Alliance, the Meharry Clinical and Translational Research Center (MeTRC), and centers focused on AIDS and health policy. Funding comes largely from the National Institutes of Health and the Health Resources and Services Administration, with additional support from the Centers for Disease Control and Prevention, foundations, and industry collaborations. The college partners with Nashville General Hospital and regional health systems to translate discoveries into community-based care, clinical trials, and workforce training. Strengths translate to applications in preventive and community health interventions, diagnostics, oral health innovations, data‑driven health services, and precision medicine.

Top industry applications

Halo’s AI pipeline combines publication data and faculty input to determine the industry applications with greatest concentration of publishing faculty. It then surfaces those with the strongest industry collaboration evidence.
Medicine
Oncology & cancer therapeutics
Meharry researchers target aggressive triple-negative breast and castration-resistant prostate cancers by exploiting metabolic and immune vulnerabilities to overcome drug resistance. Their pipeline includes novel immunomodulators, parasite-derived biotherapeutics, and multi-ancestry biomarker platforms that address stark cancer health disparities. These programs pave the way for next-generation targeted therapies and companion diagnostics tailored to underserved populations.
Medicine
Medical diagnostics
Meharry Medical College is advancing AI-driven diagnostics and biomarker platforms to detect melanoma, prostate cancer, and lung nodules earlier and more equitably across diverse patient populations. Researchers are translating machine-learning histopathology, EMR-integrated risk assessments, and point-of-care screening tools into practical solutions that address racial disparities in medical testing. This work opens commercial pathways for precision diagnostics that improve outcomes in underserved communities while meeting growing market demand for equitable, scalable health technologies.
Medicine
Cardiovascular health
Meharry Medical College researchers are harnessing plasma biomarkers and AI-driven cardiac imaging to predict stroke, stratify hypertension risk, and personalize cardiovascular therapy. They are also targeting immune-metabolic mechanisms behind salt-sensitive hypertension and ischemic injury to advance novel therapeutics. Much of this work directly addresses racial and socioeconomic disparities, creating commercial opportunities in inclusive clinical trial design and community-based care models.
Last updated by Halo AI Mar 27, 2026. Please verify key information.
OpenAlexOpenAlex
For general inquiries
Have a specific need?
Post a free request to Meharry Medical College faculty.
Top industry applications
Oncology & cancer therapeuticsMedical diagnosticsCardiovascular health
Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.